Kenneth E. "Skeeter" Clark (1951 - 2010)

While in treatment, Skeeter participated in Duke University’s clinical trials for lung cancer treatment knowing that it may not help him, but that it would help someone in the future. Skeeter’s Lazy Links Classic keeps his desire to help others a priority as all proceeds will benefit the Duke Cancer Institute’s lung cancer research programs.

Since September 2010, Skeeter's Foundation has given over $23,000 to the Duke Cancer Institute's lung cancer research programs. Thank you for all of your support!

Skeeter's Foundation is a 501(c)(3) public charity.

More people in the United States die from lung cancer than from colon, breast, prostate and pancreatic cancers combined. The five-year survival rate for all stages of lung cancer combined is 15 percent. However, the survival rate is approximately 50 percent when localized.

The Thoracic Oncology Program at Duke is dedicated to advancing the care and outcomes of patients with lung cancer, mesothelioma, and other thoracic cancers. The individualized care offered by the Duke Thoracic Oncology Program improves patients’ outcomes and quality of life during and after treatment.